Basking Biosciences, Inc
Basking Biosciences is a clinical-stage biopharmaceutical company redefining how potentially life-threatening blood clots are treated. Its novel, investigational therapies are designed to significantly improve safety and efficacy, broadening access to many more patients. Its lead program, BB-031, is the first rapid-onset, short-acting thrombolytic therapy with a reversal agent, currently in development for the treatment of acute ischemic stroke (AIS). By inhibiting von Willebrand Factor (vWF), a key driver in clot formation, BB-031 aims to deliver targeted, potent thrombolytic activity that could enable more patients to receive timely, life-saving treatment after stroke.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
13
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Basking Biosciences, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Basking Biosciences, Inc
1 distinct titles indexed · top 1 shown.
- 1vp, global drug development
Sign up to unlock all 2 contacts at Basking Biosciences, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Basking Biosciences, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.